Skip to main content
BCBS federal program to cover Interpace Dx's thyroid cancer tests
11/8/2018

Interpace Diagnostics has scored a reimbursement win from the Blue Cross Blue Shield federal program for its ThyGeNEXT and ThyraMIR thyroid cancer tests.

Full Story: